advisorsecurities master

RNXTRenovoRx, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
21080
Ticker
RNXT
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2021-08-26
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
RNXT

Detail

Enriched 2026-08-14 20:47

Market cap
$50,511,028.96
Shares outstanding (class)
45,052,706
Shares outstanding (weighted)
45,099,133
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
17
Location
MOUNTAIN VIEW, CA
Description

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data